Open-Ended Responses

Total Page:16

File Type:pdf, Size:1020Kb

Open-Ended Responses Progress and Problems: Government Scientists Report on Scientific Integrity at Four Agencies Appendix D: Open-ended Responses Below are all open-ended responses received on the survey. Responses have not been edited for grammar or spelling errors. They are displayed as respondents wrote them, with identifying information redacted to protect anonymity. In some cases, large portions of responses had to be concealed to protect the identities of respondents. Question 39. How do you think the mission of the [AGENCY] and the integrity of the scientific work produced by the [AGENCY] could best be improved? The below open-ended responses are sorted by agency and categorized by subject, in order of frequency. The percentages in each category represent the proportion of coded text on that topic, rather than the proportion of respondents. CDC Twenty-six percent (467) of the 1,764 CDC survey respondents provided written responses. Management and Leadership (Mentioned in 26% of coded responses) Reduce/relax the beaurocratic procedures especially regarding publication of scientific work As a leading federal government agency, CDC should pay more attention to avoid nepotism within the same unit (branch or maybe division). This is especially a problem in the leadership level. It created unfair situation to other employee. People who enjoy these advantage often tend to chose their own favorite colleagues in important tasks, or assignments. This in turns created more opportunities to promote people of their own circle. The best man/woman for the particular task could therefore sacrifice because of this established culture of nepotism. OMB is a pain in the ass - the Paperwork Reduction Act is a joke. It significantly hampers CDC's ability to quickly assess emerging situations, including outbreaks, due to its imposition of burdensome requirements for approval of assessment tools. The IRB exists to ensure that CDC staff conduct research that is in line with scientific core values (Justice, Autonomy, Beneficence). OMB seems to exist solely to make work more difficult. Would be good to remove some of the Associate Director of Science barriers to publishing recommendations as the science suggests - rather than how the ADS wishes them to be published. The bias of senior management toward epidemiology and toward graduates of the Epidemic Intelligence Service Training Program as it all time high levels. Many senior managers (from Branch level up) have minimal laboratory science training but they are tasked with directing the work of laboratory staff. This is an old issue that originated with the origination of the CDC from laboratory and epidemiology parts of the public health service. It has proceeded to the point that few senior managerial hires come from institutions outside the CDC and it is almost considered a right of passage for EIS staff to move from training to team leads, then to branch chiefs, then to Division 1 Directors, then Center Directors, and even to CDC director. Many bench scientists often wonder if it is possible to do science at the CDC and competitive projects and postdoctoral positions that are approved must pass through a heavy handed application of "public health" qualifications. Support and strengthen (regain CDC's status in) experimental laboratory research. Integrity, I can't imagine, but maybe removal of ILB's top management. I work in a small office. The delay or release of our science is due to the fact that managers are so overloaded and unable to delegate. The lack of trust between them makes them very "possessive" of their scientific projects which impedes cooperation and creativity. TRUST: trust the scientists to do their jobs. There is a pervasive feeling of distrust from above among the scientists. This is evidenced by the programs being implemented such as the Laboratory Safety Committee (How many millions of man-hours have NOT resulted in accidents? How many millions of dollars have been spent making new rules when the issue came from a couple of people who did nto follow established rules?), and the nonsensical time-drain, QMS. Speed up approval procedures on urgent work and remove unnecessary bureaucratic hurdles of which there are many The administrative tasks have increase significantly over the last 5 five and are affecting the research effort. More interagency intrrac Structuring the organization where scientists can maximize their scientific expertise and assistance while diminishing the administrative load. Also, leadership appears generally to consist of medical officers with little to no competence-based training in leadership, management, and work-force ethics. This, in my experience, produces tension due to the lack of understanding or appreciation of staff, and inhibits support of scientific integrity. The CDC management need to engage them selves and support the the scientific community in all process of scientific work To diversify scientific directions across CDC laboratories while keeping priorities for some research problems I think the best way for improvement is getting back to doing science and staying out of politics. This is best accomplished by hiring the smartest person available to do the job. Many years ago this was the practice and it is why the US was so strong technically that peaked in the 1960's. But since that time politics has eroded this hiring practice as the current people being promoted have political skills and are far less technically educated but can enforce the wishes of the boss. It has become corrupt. There is no fairness. For any new promotion a person has already been selected by management. It is a power game where the objective is to keep it and gather more. The people needed to solve the technical problems are just a task that needs to make some progress. Keeping power, just like in politics, is management's major concern. So small numbers of technical people are kept to do the bare minimum of work. Lip service is given to the importance of this scientific work but the reality is that the engineers and scientists are not promoted. I am a PhD research engineer with ## years of experience and have published dozens of papers and I am still a GS-12 step## but I am not the only one like this at my office. The newest job opening here is for a branch 2 chief. It will be a GS-14. The applicant has already been selected by the boss via the grapevine news and will be my new supervisor with a B.S. degree in engineering. It happens all the time.. Apply disciplinary action equally to the managers and the perpetrators. Have all the Directors for Science and the Human Subjects Reviewers under the supervision of the Associate Directors for Science at each organizational level. For example, The center ADSs are supervised by the Center directors, and not by the Agency ADS. the Division ADS reports to the Division director and not to the Center ADs. The country based ADSs report to the Country Director and not to their home based ADS. Decreasing the pushing down of administrative duties to the subject matter experts and let them get back in the lab with the junior scientists. In the prior decades, jr. scientists were trained by the Sr. scientists in the labs or epi offices. Now we hire contractors and fellows, give them an online training safety course and turn them loose because we are so tied up with surveys and paperwork to actually do science. The safety issues of late were ALL inexperienced scientists not the long term ones. The reason, the long term scientists were trained by Sr. scientists in the lab with them. Now they are on their own. reduction of the myriad of other agency requirements like OMB that essentially create incredible hurtles that require the agencies to expend their resources on internal bureaucracy instead of doing the work of public health. Greater understanding and support of CDC leadership for ALL agencies that make-up CDC. Eliminate the Atlanta centric thinking of CDC leadership and operations to greater recognize and support CDC components that are not located in Atlanta or the state of Georgia. There is a overwhelming trend at CDC to make the laboratories conform to one size fits all protocols and proceedures and software packages. I am retired now, but the mandated systems that are being forced upon my former lab were unworkable and irrelevent to the actual laboratory mission. Mandates from HHS and the Director are interpreted by supervisory staff in a multiple ways, leaving the branch with 5 to 6 different interpretations of what we are being told to do. This results in bench level laboratory personel reaching the obvious conclusion that the supervisory chain is hopelessly inept, confused or incompatent. We have spent so much time writing and re-writing documents due to "wishy washy" and contradictory directions, that our moral has literally hit the toilet. Cut the bureaucracy, and stay focused on the mission of public health. Empowering senior and other level scientists with more influence on management policy and decisions; management and leadership structure and bias are too hierarchical and industry like. Survey scientists on how to recruit and retain scientific talent. I would recommend improving timely and accurate assistance with administrative tasks when coming on board at CDC. There is a huge communication gap between HR and security in Atlanta and other CDC sites. The process is extremely disorganized and dysfunctional. Lots of time was wasted (repeatedly emailing, calling, etc.) when coming on board which hinders the scientific work CDC hired me to do. On the Division and Branch level scientific work is completed with upmost integrity and diligence. 3 By looking at all the moving pieces that influence the mission and scientific work of the CDC.
Recommended publications
  • Request for Information to Improve Federal Scientific Integrity Policies (86 FR 34064)
    July 27, 2021 Office of Science and Technology Policy Executive Office of the President Eisenhower Executive Office Building 1650 Pennsylvania Avenue Washington, DC 20504 Submitted electronically to [email protected] Re: Request for Information to Improve Federal Scientific Integrity Policies (86 FR 34064) The American Association for the Advancement of Science (AAAS), Association of American Medical Colleges (AAMC), Association of American Universities (AAU), Association of Public and Land-grant Universities (APLU), and Council on Governmental Relations (COGR), collectively the “Associations,” appreciate the opportunity to provide feedback to the White House Office of Science and Technology Policy (OSTP) to help improve the effectiveness of Federal scientific integrity policies in enhancing public trust in science. The Associations strongly support the efforts of the White House in addressing issues of federal scientific integrity and public trust in science. We further appreciate the swift issuance of the Presidential Memorandum on Restoring Trust in Government Through Scientific Integrity and Evidence-Based Policymaking and establishment of the Scientific Integrity Task Force. These actions seek to formalize and standardize scientific integrity through an all-of-government approach. Protecting the integrity of science and ensuring the use of evidence in policymaking should be a national priority across administrations. These efforts come at a critical time for the United States. Public trust in federal science has been shaken by anti-science rhetoric, lack of transparency, and questions about the integrity of science conducted and supported by the federal government. At the same time, building and maintaining trust in this science has never been more important as we confront continuing threats, including a global pandemic and climate change.
    [Show full text]
  • Policy on Scientific Integrity
    وزارة اﻟﺘﻌﻠﯿﻢ MINISTRY OF EDUCATION ﺟـﺎﻣﻌﺔ اﻟﺪﻣـﺎم UNIVERSITY OF DAMMAM اﻟﻤﺠﻠﺲ اﻟﻌﻠﻤﻲ THE SCIENTIFIC COUNCIL Policy on Scientific Integrity Part I Rules & Regulations Policy on Scientific Integrity 2 Table of Contents Article Pages # Introduction 4 Definition of Scientific Misconduct in Research & 4 Scientific Studies General Rules of Scientific Integrity 5 Prevention of Scientific Misconduct in Research & 10 Scientific Studies Violations of Scientific Integrity 11 Management of Possible Scientific Misconduct 13 Record Retention 14 Applicability 15 General Definitions 15 Acknowledgements 22 Appendices 22 NSTIP Rules of Scientific Integrity 22 3 Policy on Scientific Integrity 1. Introduction The University of Dammam (UOD) espouses to maintain the highest standards of research ethics and scientific integrity. To that end, UOD has developed a series of policies and associated initiatives to promote a culture of scientific integrity and research ethics in the conduct of all aspects of its research mission. This commitment includes programs to educate all institutional members of such standards and to monitor the conduct of all scientific endeavors. This Policy for Scientific Integrity consists of four parts. They are: Part I: Rules and Regulations Part II: Rules for Scientific Publications, Authorship and Copyrights Part III: Research Conflict of Commitment and Conflict of Interest Part IV: Procedures for Evaluation and Management of Scientific Misconduct and Research Conflict of Commitment & Conflict of Interest In their collective, these parts articulate the institutional guidelines for proper scientific conduct and provides a detailed description of the institution’s management of any potential aberration to that standard. 2. Definition of Misconduct in Scientific Research Integrity Misconduct in research and scientific studies means fabrication, falsification, and/or plagiarism, in proposing, performing, or reviewing research, or in reporting research results.
    [Show full text]
  • Science and Technology Issues in the 117Th Congress
    Science and Technology Issues in the 117th Congress May 5, 2021 Congressional Research Service https://crsreports.congress.gov R46787 SUMMARY R46787 Science and Technology Issues in the 117th May 5, 2021 Congress Frank Gottron, The federal government supports scientific and technological advancement directly by funding Coordinator and performing research and development, and indirectly by creating and maintaining policies Specialist in Science and that encourage private sector efforts. Additionally, the federal government regulates many Technology Policy aspects of S&T activities. This report briefly outlines a key set of science and technology policy th issues that may come before the 117 Congress. Brian E. Humphreys, Coordinator Many of these issues carry over from previous Congresses, and represent areas of continuing Analyst in Science and Member interest. Examples include policies on taxation, trade, intellectual property, Technology Policy commercialization of basic scientific research and other overarching issues that affect scientific and technological progress. Other issues may represent new or rapidly evolving areas affected by the threats of pandemic diseases, climate change, and malicious cyber activities, among others. Examples covered in this report include infectious disease modeling and forecasting, digital contact tracing and digital exposure notification, hydrogen pipelines, and expansion of emerging information and communications technologies such as 5G. These and other S&T-related issues that may come before the 117th Congress are grouped into 10 categories. Overarching S&T Policy Issues, Agriculture, Biotechnology and Biomedical Research and Development, Climate Change and Water, Defense, Energy, Homeland Security, Information Technology, Physical and Material Sciences, and Space. Each of these categories includes concise analysis of multiple policy issues.
    [Show full text]
  • ENERI Manual Research Integrity and Ethics
    ENERI Deliverable D3.1 Appendix: Manual ENERI Manual Research Integrity and Ethics Bart Penders | David Shaw | Peter Lutz | David Townend Lloyd Akrong | Olga Zvonareva Maastricht University 1 Table of Contents Introduction: the manual to the manual .................................................................................................. 3 It’s alive .......................................................................................................................................... 3 1. Research Integrity ............................................................................................................................... 4 1.1. Conceptual issues ........................................................................................................................ 5 1.1.1. The Researcher in Society - towards the “virtuous researcher” ........................................... 5 1.1.2 Research, Evidence and Truth? ............................................................................................. 9 1.1.3 Detrimental Research Practices and Research Misconduct ................................................. 12 1.1.4 Social Responsibility .......................................................................................................... 14 1.2. Practical Issues .......................................................................................................................... 18 1.2.1. Plagiarism ..........................................................................................................................
    [Show full text]
  • Scientific Integrity
    Scientific Integrity SCIENTIFIC INTEGRITY The Rules of Academic Research by Kees Schuyt Translated by Kristen Gehrman LEIDEN UNIVERSITY PRESS Translation: Kristen Gehrman Cover design: Geert de Koning Lay-out: Friedemann bvba ISBN 978 90 8728 230 1 e-ISBN 978 94 0060 218 2 (PDF) e-ISBN 978 94 0060 219 9 (ePUB) nur 737, 738 © Kees Schuyt / Leiden University Press, 2019 This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License. To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc/4.0/. This book is distributed in North America by the University of Chicago Press www.press.uchicago.edu. Table of contents Foreword 7 Introduction 9 Chapter 1 Scientific integrity: an exploration of an elusive concept 13 1.1 Discredited by fraud 13 1.2 Integrity as a standard linked to one’s position 15 1.3 Integrity as a standard for one’s own behavior 18 1.4 Scientific values and the basic standards of integrity 21 1.5 Scientific integrity in practice: an initial exploration 25 Chapter 2 The codification of behavioral standards for scientific research 31 2.1 Muddying the waters of science: the Stapel affair 31 2.2 Some examples of fraud 32 2.3 Four conceptual distinctions 35 2.4 The emergence of norms in scientific practice 36 2.5 A case study: the codification of norms in the Netherlands 41 2.6 The Netherlands Code of Conduct for Scientific Practice of 2004/2012/2014 45 2.7 The Netherlands Code of Conduct for Research Integrity of 2018 49 Chapter 3 Scientific fraud: lessons from history
    [Show full text]
  • White Paper on Promoting Integrity in Scientific Journal Publications, 2012 Update
    CSE’s White Paper on Promoting Integrity in Scientific Journal Publications, 2012 Update Editorial Policy Committee (2011-2012) www.CouncilScienceEditors.org CSE’s White Paper on Promoting Integrity in Scientific Journal Publications, 2012 Update Editorial Policy Committee (2011-2012) www.CounsilScienceEditors.org Kristi Overgaard (Chair) Daniel Salsbury American Orthopaedic Society for Sports Medicine Proceedings of the National Academy of Sciences Patricia Baskin Mary Scheetz American Academy of Neurology Research Integrity Consulting, LLC Elizabeth Blalock Diane Scott-Lichter Journal of Investigative Dermatology American Association for Cancer Research Howard Browman Gene P. Snyder Institute of Marine Research, Storebø, Norway Envision Pharma Bruce Dancik Anna Trudgett NRC Research Press, University of Alberta American Society of Hematology Wim D’Haeze Arena Pharmaceuticals, Inc. Editorial Policy Committee (2008-2009) Robert L. Edsall Heather Goodell (Chair) American Academy of Family Physicians American Heart Association Jill Filler Elizabeth Blalock American Society for Pharmacology and Experimental Therapeutics Journal of Investigative Dermatology Heather Goodell Bruce Dancik American Heart Association NRC Research Press, University of Alberta Angela Hartley Robert L. Edsall Association of Women’s Health, Obstetric and Neonatal Nurses American Academy of Family Physicians Kenneth Kornfield Jill Filler American Society of Clinical Neurology American Society for Pharmacology and Experimental Therapeutics Christine Laine Angela Hartley
    [Show full text]
  • Preserving Scientific Integrity in Federal Policymaking Lessons from the Past Two Administrations and What’S at Stake Under the Trump Administration
    Preserving Scientific Integrity in Federal Policymaking Lessons from the Past Two Administrations and What’s at Stake under the Trump Administration {cSD Cente rfor Science and Democracy at the Union of Concerned Scientists Preserving Scientific Integrity in Federal Policymaking Lessons from the Past Two Administrations and What’s at Stake under the Trump Administration Gretchen Goldman Genna Reed Michael Halpern Charise Johnson Emily Berman Yogin Kothari Andrew Rosenberg January 2017 © 2017 Union of Concerned Scientists All Rights Reserved Gretchen Goldman is the research director in the Center for Science and Democracy at the Union of Concerned Scientists (UCS). Genna Reed is the science and policy ana- lyst in the Center. Michael Halpern is the deputy director of the Center. Charise Johnson is the research associate in the Center. Emily Berman is the research as- sistant in the Center. Yogin Kothari is the Washington representative in the Center. Andrew Rosenberg is the director of the Center. The Union of Concerned Scientists puts rigorous, independent science to work to solve our planet’s most pressing problems. Joining with citizens across the country, we combine technical analysis and effective advocacy to create innovative, practical solutions for a healthy, safe, and sustainable future. The Center for Science and Democracy at UCS works to strengthen American democracy by advancing the essential role of science, evidence-based decisionmaking, and constructive debate as a means to im- prove the health, security, and prosperity of all people. More information about UCS and the Center for Science and Democracy is avail- able on the UCS website: www.ucsusa.org This report is available online (in PDF format) at www.ucsusa.org/ PreservingScientificIntegrity.
    [Show full text]
  • Rhetoric Across Borders
    DEMO RHETORIC ACROSS BORDERS features twenty-one essays and six excerpts from the “In Conversation” panels convened at the sixteenth Biennial Rhetoric Society of America (RSA) Conference. Participants engaged the conference theme of “Border RHETORIC RHETORIC Rhetorics” in ways that not only reinvigorated the border as a conceptual metaphor but also challenged boundaries within rhetorical scholarship. Although the volume includes only a select representation of the work presented at the conference, each section features the diverse perspectives offered in Composition ACROSS and Communication. The first section,Between Materiality and Rhetoric, explores points of interface between rhetoric and materiality. Working from diverse periods and disciplinary orientations, the authors illuminate how attending to the mutuality between materiality and rhetoric engenders a productive revision and/or expansion of our approaches to essential aspects of rhetorical inquiry. The second section,Crossing ACR BORDERS Cultures: Refiguring Audience, Author, Text, and Borders, explores how various forms of translation, migration, and liminality can refigure our understanding of the interplay between audience, author, and text. Essays in the third section, Remapping the Political, OSS examine the diverse genres that broaden our understanding of the res publica and the tactics employed to circumscribe politics. In the fourth section, Contesting Boundaries: Science, Technology, and Nature, authors consider how shifting notions of expertise and competing epistemologies alter our conceptions of science and the environment. The selected essays in the final section,Teaching Across Divides, explore the different BORDERS boundaries that shape teaching in rhetoric and composition. Here, the authors reflect on the challenges and rewards gained by explicitly engaging the borders and boundary- work that often remains invisible to our students.
    [Show full text]
  • Informed Decision Making During Pregnancy: Risk Consideration in Clinical Practice and Research
    Western University Scholarship@Western Electronic Thesis and Dissertation Repository 3-22-2016 12:00 AM Informed Decision Making During Pregnancy: Risk Consideration in Clinical Practice and Research Kyoko Wada The University of Western Ontario Supervisor Marilyn Evans The University of Western Ontario Joint Supervisor Jeff Nisker The University of Western Ontario Graduate Program in Health and Rehabilitation Sciences A thesis submitted in partial fulfillment of the equirr ements for the degree in Doctor of Philosophy © Kyoko Wada 2016 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Medical Education Commons Recommended Citation Wada, Kyoko, "Informed Decision Making During Pregnancy: Risk Consideration in Clinical Practice and Research" (2016). Electronic Thesis and Dissertation Repository. 3636. https://ir.lib.uwo.ca/etd/3636 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. Abstract This thesis addressed a cluster of issues related to risk and the pregnant woman’s decision making in clinical practice and research. In terms of clinical practice, the minimal risk concept - a low risk standard codified in research ethics regulations - was applied to clinicians’ information provision to the patient. As clinicians must discuss a variety of health risks, minimal risk standards may be useful as a threshold to demarcate risks that clinicians should discuss with the patient. Application of minimal risk standards to risk factors in pregnancy showed the usefulness and limitations of these standards.
    [Show full text]
  • Scientific Integrity
    Scientific integrity Andrea Saltelli Open Evidence Research, Open University of Catalonia INPhINIT PhD training sessions, Virtual, CaixaForum, April 9, 2021 Where to find this talk: www.andreasaltelli.eu Definition of integrity 1 : firm adherence to a code of especially moral or artistic values : incorruptibility 2 : an unimpaired condition : soundness 3 : the quality or state of being complete or undivided : completeness Definition of integrity 1 : firm adherence to a code of especially moral or artistic values : incorruptibility The ethos of open science: CUDOS, by R.K. Merton, a system of universal norms Robert K. Merton R. Merton, The sociology of science: Theoretical and empirical investigations, 1973. Communalism - the common ownership of scientific discoveries, according to which scientists give up intellectual property rights in exchange for recognition and esteem (Merton actually used the term Communism, but had this notion of communalism in mind, not Marxism); Universalism - according to which claims to truth are evaluated in terms of universal or impersonal criteria, and not on the basis of race, class, gender, religion, or nationality; Disinterestedness - according to which scientists are rewarded for acting in ways that outwardly appear to be selfless; Organized Skepticism - all ideas must be tested and are subject to rigorous, structured community scrutiny. Go to https://calteches.library.calt ech.edu/51/2/CargoCult.htm or buy the book … read Caltex’s speech (1974) of Richard Feynman about what organized scepticism is about
    [Show full text]
  • Scientific Integrity Policies at Key Federal Agencies
    A QUICK GUIDE Scientific Integrity Policies at Key Federal Agencies What federal scientists should know and do if they sense political interference with their research. Brought to you by the Climate Science Legal Defense Fund Table of Contents Introduction 2 Scientific Integrity Policies at a Glance 4 Centers for Disease Control and Prevention (CDC) 7 Department of Defense (DOD) 19 Department of Energy (DOE) 27 Department of the Interior (DOI) 37 Environmental Protection Agency (EPA) 49 National Aeronautics and Space Administration (NASA) 59 National Oceanic and Atmospheric Administration (NOAA) 71 National Science Foundation (NSF) 83 United States Department of Agriculture (USDA) 95 Acknowledgments 108 Introduction This guide covers the scientific integrity policies of nine federal agencies. It will help researchers employed by these agencies understand and navigate the process of filing a scientific integrity complaint. Scientific Integrity at Federal Agencies Scientific integrity principles are indispensable to the missions and the functions of science-related agencies in the United States. Their ability to conduct sound, unbiased scientific research is essential to maintaining public trust in these agencies. Following a 2009 memorandum issued by President Obama and a 2010 memorandum issued by the White House Office of Science and Technology Policy, many agencies adopted formal scientific integrity policies intended to ensure that the science these agencies rely on for decision-making is free from fraud, fabrication, and plagiarism. Scientific integrity policies help ensure that the work of agency scientists is communicated in a transparent and timely manner to the public and decision-makers. The policies can protect federal scientists from censorship and intimidation, and from having their work altered or ignored for political reasons.
    [Show full text]
  • Politicization of Science: How Climate Change Skeptics Use Experts and Scientific Evidence in Their Online Communication Hannah
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Bern Open Repository and Information System (BORIS) 1 POLITICIZATION OF SCIENCE Politicization of science: How climate change skeptics use experts and scientific evidence in their online communication Hannah Schmid-Petri University of Passau Dr.-Hans-Kapfinger-Str. 12 94030 Passau, Germany email: [email protected], phone: +49-(0)851-509-3420 Abstract: This study, using the discussion about climate change in the United States as an example, ana- lyzes the research question of how climate change skeptics use experts and scientific evidence in their online communication. Two different strategies are distinguished: legitimation and crit- icism. The study conducts a quantitative content analysis of online documents to answer the research question. The results show that the deduced strategies are an important part of the communication of climate change skeptics, who more commonly use the criticism strategy than the legitimation strategy. Results are further differentiated for different actor types and various types of experts. Keywords: expert, expert knowledge, online communication, uncertainty, climate change Acknowledgments: This publication was created in the context of the Research Unit "Political Communication in the Online World" (1381), subproject 7, which is funded by the DFG, German Research Foundation. The subproject is also funded by the Swiss National Science Foundation (SNF, 100017E-135915). 2 POLITICIZATION OF SCIENCE Politicization of science: How climate change skeptics use experts and scientific evidence in their online communication 1 Introduction Political issues and public controversies often refer to scientific knowledge (e.g. about health or environmental protection; Scheufele 2014).
    [Show full text]